WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura Lee SandlerChief Operating Officer2026-07-015,000$7.80
$39.00kBuy
Laura Lee SandlerChief Operating Officer2026-07-012,237$93.85
$209.93kSell
Laura Lee SandlerChief Operating Officer2026-07-012,263$94.75
$214.41kSell
Laura Lee SandlerChief Operating Officer2026-07-01500$95.47
$47.74kSell
Fairmount Funds Management LLCDirector2026-07-013,553,410$84.43
$300.01MSell
Arjun AgarwalSenior Vice President Finance2026-06-22888$80.01
$71.05kSell
Arjun AgarwalSenior Vice President Finance2026-06-22699$82.15
$57.42kSell
Arjun AgarwalSenior Vice President Finance2026-06-15395$69.69
$27.53kSell
Joana GoncalvesChief Medical Officer2026-06-15947$69.69
$66.00kSell
Joana GoncalvesChief Medical Officer2026-06-15300$70.62
$21.19kSell

1 of 9

ORKA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Anthony A. Florence Jr.16.95%10,221,465$870.97MInsider
Ravi Viswanathan16.95%10,221,465$870.97MInsider
Joshua Makower16.95%10,221,465$870.97MInsider
Harry R. Weller16.95%10,221,465$870.97MInsider
Scott D. Sandell16.95%10,221,465$870.97MInsider
David M. Mott16.95%10,221,465$870.97MInsider
Jon Sakoda16.95%10,221,465$870.97MInsider
Forest Baskett16.95%10,221,465$870.97MInsider
Peter J. Barris16.95%10,221,465$870.97MInsider
Krishna Kittu Kolluri16.95%10,221,465$870.97MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA25.55%74.45%Net SellingNet Selling
DNTH65.57%34.43%Net BuyingNet Buying
CAI41.85%58.15%Net SellingNet Selling
CELC80.59%19.41%Net BuyingNet Selling
TVTX63.57%36.43%Net SellingNet Selling
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 87.51% institutional shareholders, 255.04% Oruka Therapeutics insiders, and 0.00% retail investors. Anthony A. Florence Jr. is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 16.95% of the company. Anthony A. Florence Jr.'s Oruka Therapeutics shares are currently valued at $870.97M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.